Lung Cancer News

Implementation of lung cancer screening across five diverse health care systems led to higher rates of stage I diagnoses and lower rates of stage IV disease, study results showed.

Genomic testing continues to provide oncologists with a wealth of meaningful, treatment-guiding information for a growing number of cancers.

Spaceflight may place astronauts at increased risk for developing mutations that can lead to cancer and heart disease, according to a study published in Nature Communications Biology.

Higher allostatic load, a measure of lifelong stress, correlated with increased risk for cancer mortality, especially among younger populations, according to study results published in SSM Population Health.

Patient navigation programs have historically been difficult to implement on a large scale.

Medical marijuana legalization enacted from 2012 to 2017 appeared associated with a lower rate of opioid prescriptions and pain-related hospitalization among some adults being treated for newly diagnosed cancer, according to a study.

Increasing costs of cancer care and greater cost-sharing resulted in higher out-of-pocket costs for nonelderly, privately insured patients with breast, colorectal, lung and prostate cancers, according to study results.

2022 has brought many research updates and approvals in lung cancer.

A dramatic rise in global incidence of early-onset cancers over the past 30 years may be related in part to increased exposure to risk factors at a young age, according to study results published in Nature Reviews Clinical Oncology,

The FDA issued a complete response letter to Spectrum Pharmaceuticals indicating it could not approve the company’s new drug application that sought approval of poziotinib as treatment for certain patients with lung cancer.